CTI Clinical Trial and Consulting Services Announces Multiple Office Expansions - Applied Clinical Trials

ADVERTISEMENT

See our 2013 Buyers Guide Digital Edition.
CTI Clinical Trial and Consulting Services Announces Multiple Office Expansions

Source: Company News Release
CTI Clinical Trial and Consulting Services (CTI) announces the expansion of its offices in Cincinnati, Ohio (Global Headquarters); Raleigh, North Carolina; Madrid, Spain; and Ulm, Germany (European Headquarters).

“This reflects continued growth of the company due to new business awards from our current pharmaceutical and biotechnology sponsors,” according to Timothy J. Schroeder, CTI CEO and President. “We are very fortunate to have long term relationships with these sponsors, in some cases for more than a decade, and they continue to partner with us. We are extremely grateful for the opportunities.”

CTI currently works with more than 60 pharmaceutical and biotechnology companies, including eight of the ten largest global companies. These office expansions will allow for expanded capabilities and additional personnel across all departments.

ADVERTISEMENT

blog comments powered by Disqus

ADVERTISEMENT

UPCOMING CONFERENCES

8th Annual Forum on Transparency and Aggregate Spend 2014
Washington, DC
August 18-20, 2014

eSource Data in Clinical Investigations
Philadelphia, PA
August 20-21, 2014

Pharmacovigilance 2014
Philadelphia, PA
September 10-11, 2014

Collaborative Research Summit
Philadelphia, PA
October 15-16, 2014

See All Conferences >>

Survey
As it creates a plan to implement the US biosimilar pathway, should FDA:
Borrow heavily from EMA's pathway program?
Borrow lightly from EMA's pathway program?
Create entirely its own pathway program?
Borrow heavily from EMA's pathway program?
87%
Borrow lightly from EMA's pathway program?
6%
Create entirely its own pathway program?
8%
View Results
Untitled Document
Source: Company News Release,
Click here